https://www.renbio.com/news_and_events/renbio-announces-new-awards-to-support-continued-development-of-its-novel-dna-based-myo-technologytm-platform-for-antiviral-applications/
David D. Ho, MD, RenBio Co-founder
                    Yaoxing Huang, PhD, RenBio Co-founder

Meet RenBio's co-founders

David D. Ho, MD and
Yaoxing Huang, PhD

Drs. Ho and Huang have collaborated on several successful scientific projects over more than 25 years and have advanced multiple vaccine and antibody candidates from the bench to the bedside. RenBio is the fruition of their latest collaborative endeavor.

Co-founders

Back

MEET OUR TEAM

Key Advisors and Consultants